Edition:
India

People: Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

46.65USD
1:30am IST
Change (% chg)

$0.73 (+1.59%)
Prev Close
$45.92
Open
$45.83
Day's High
$46.86
Day's Low
$45.63
Volume
115,457
Avg. Vol
169,713
52-wk High
$51.49
52-wk Low
$31.98

Klassen, Preston 

Dr. Preston S. Klassen, M.D., M.H.S. is an Executive Vice President - Research & Development, Chief Medical Officer of the Company. Dr. Klassen has over 20 years of experience in biopharmaceutical product development. Most recently, he was Chief Medical Officer of Laboratoris Sanifit S.L. and prior to that was Executive Vice President, Head of Global Development at Orexigen Therapeutics, Inc. Previously, Dr. Klassen held several positions of increasing responsibility at Amgen Inc., including Therapeutic Area Head for Nephrology. Prior to joining Amgen, he was a faculty member in the Division of Nephrology atDuke UniversityMedical Center. Dr. Klassen received his medical degree from theUniversity of NebraskaCollege of Medicine and completed his residency in internal medicine, fellowship in nephrology, and masters in health sciences degree at Duke University.

Basic Compensation

Total Annual Compensation, USD 685,737
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,101,540
Fiscal Year Total, USD 1,787,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tina Nova

193,840

Amit Munshi

2,915,940

Kevin Lind

1,565,960

Steven Spector

1,599,320

Vincent Aurentz

1,612,650

Preston Klassen

1,787,280
As Of  31 Dec 2017